However, when DCs loaded with MAGE-AX were used, there has been increase in survival, a reduction of tumor size in mice with melanoma, and development of a specific immune response dependent on CD8 T cells and IFNγ production [23, 43]. This evidence concerns the gene IFNG and melanoma.